Eric Messner

CNS pipeline · person

Eric Messner, MBA

Chief Executive Officer of Emalex Biosciences, where he leads the company's mission to develop treatments for central nervous system disorders. He has more than 35 years of biopharmaceutical leadership experience spanning commercial strategy and operations. Previously he served as VP of Sales and Marketing at Marathon Pharmaceuticals, CEO of Anagin, and held senior roles at OPKO Health including General Manager and EVP of Sales and Marketing; he co-founded Proventiv Therapeutics. He earned his MBA from Northwestern University's Kellogg School of Management and a B.S. in Business Administration from Miami University.

  • 1 company

Courtesy Emalex Biosciences

Current roles

Appears with

People sharing a company with Eric.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.